CORT
Corcept Therapeutics Incorporated
Stock
$116.23+2.20 (+1.93%)Close Oct 2, 2026
- Operating cash flow, 2025
- $142M
- YoY, 2025
- −28.4%
- 5-year CAGR
- −1.3%
- 10-year CAGR
- +46.4%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $142M | −28.4% |
| 2024 | $198M | +56.5% |
| 2023 | $127M | +5.3% |
| 2022 | $120M | −28.3% |
| 2021 | $168M | +10.5% |
| 2020 | $152M | +11.6% |
| 2019 | $136M | +17.7% |
| 2018 | $116M | +89.8% |
| 2017 | $61M | +231.3% |
| 2016 | $18M | +487.6% |
| 2015 | $3.1M | — |
| 2014 | −$27M | — |
| 2013 | −$37M | — |
| 2012 | −$36M | — |
| 2011 | −$27M | — |
| 2010 | −$22M | — |
| 2009 | −$18M | — |